TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2018

Enzalutamide for the Treatment of Androgen Receptor-Expressing Triple-Negative Breast Cancer.

Tiffany A Traina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.